Comparison Rectal Endoscopic Submucosal Dissection to Endoscopic Mucosal Resection
RESDEMR
Endoscopic Submucosal Dissection Versus Endoscopic Mucosal Resection for Sessile Polyps and Laterally Spreading Lesions of the Rectum - a Prospective Randomised Trial
1 other identifier
interventional
300
1 country
1
Brief Summary
The investigators have recently become proficient in a new, and we believe more effective technique for polyp removal. Known as Endoscopic Submucosal Dissection (ESD). ESD involves removing the polyp in one piece. It is preferable to remove the polyp in one piece as it minimises the chance of leaving residual polyp tissue behind. There have also been recent studies overseas that have shown this new technique to be quite effective. In this study, half of the patients will receive the newly developed technique of polyp removal (ESD), while the other half will receive conventional Endoscopic Mucosal Resection (EMR) treatment. This study will allow us to show which technique results in lower recurrence rates and is more effective.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2014
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2014
CompletedFirst Submitted
Initial submission to the registry
July 17, 2014
CompletedFirst Posted
Study publicly available on registry
July 24, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2019
CompletedMarch 27, 2025
March 1, 2025
4.8 years
July 17, 2014
March 25, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Recurrence
Recurrence rate - free of adenoma endoscopically and histologically on 2 subsequent examinations
18 months
Secondary Outcomes (4)
One piece resection rate
14 days
Technical success of EMR
14 days
Recurrence
up to 3 years
complication rates
14 days
Study Arms (2)
Endoscopic Mucosal Resection
ACTIVE COMPARATORParticipants randomised to this arm will receive standard of care Endoscopic Mucosal Resection for removal of their lesions.
Endoscopic Submucosal Dissection
EXPERIMENTALParticipants randomised to this arm will receive Endoscopic Mucosal Dissection to remove their lesion.
Interventions
Eligibility Criteria
You may qualify if:
- Can give informed consent to trial participation
- Lesion size 20 mm to 50 mm
- Laterally spreading or sessile polyp morphology
You may not qualify if:
- Previous resection or attempted resection of target adenoma lesion
- Endoscopic appearance of invasive malignancy
- Age less than 18 years
- Pregnancy
- Active Inflammatory colonic conditions (e.g. inflammatory bowel disease)
- Use of anticoagulant or antiplatelet agents other than aspirin less than 5 days prior to procedure
- American Society of Anesthesiology (ASA) Grade IV-V
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Westmead Endoscopy Unit
Westmead, New South Wales, 2145, Australia
Related Publications (1)
O'Sullivan T, Tate D, Sidhu M, Gupta S, Elhindi J, Byth K, Cronin O, Whitfield A, Craciun A, Singh R, Brown G, Raftopoulos S, Hourigan L, Moss A, Klein A, Heitman S, Williams S, Lee E, Burgess NG, Bourke MJ. The Surface Morphology of Large Nonpedunculated Colonic Polyps Predicts Synchronous Large Lesions. Clin Gastroenterol Hepatol. 2023 Aug;21(9):2270-2277.e1. doi: 10.1016/j.cgh.2023.01.034. Epub 2023 Feb 12.
PMID: 36787836DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michael J Bourke, MBBS
Western Sydney Local Health District
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Director of Gastrointestinal Endoscopy
Study Record Dates
First Submitted
July 17, 2014
First Posted
July 24, 2014
Study Start
July 1, 2014
Primary Completion
May 1, 2019
Study Completion
May 1, 2019
Last Updated
March 27, 2025
Record last verified: 2025-03